Ligand (LGND) Director Martine Zimmermann Sells 1,200 Shares

What Happened

• Martine Zimmermann, a director of Ligand Pharmaceuticals, reported a sale of 1,200 common shares on 2026-09-10. The shares were disposed at $285.00 each, for a total proceeds of $342,000. This is a sale (not a purchase), which is commonly routine insider selling and does not by itself indicate company prospects.

Key Details

• Transaction date and price: 2026-09-10 — 1,200 shares at $285.00 per share.
• Total value: $342,000.
• Transaction type: Reported as an open-market or private sale on the Form 4.
• Shares owned after transaction: Not specified in the provided filing excerpt — consult the full Form 4 for post-transaction holdings.
• Footnotes/plan status: No 10b5-1 plan, tax-withholding, or other footnotes were provided in the excerpt.
• Filing timeliness: Form 4 was filed 2026-09-14 for a 2026-09-10 transaction; this appears to be timely (filed within two business days).

Context

• Sales by directors are common and may be for personal liquidity, diversification, or other non-company reasons; they are less informative than purchases about insider confidence. For a full picture, compare this sale to recent insider trades and the director’s remaining holdings disclosed on the complete Form 4.